Steve Pakola
CIK: 0001700659
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
REGENXBIO Inc.
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Nov 1, 2026RGNX
REGENXBIO Inc.
Award(A)Direct34.7K shares- - Aug 1, 2026RGNX
REGENXBIO Inc.
Tax Payment(F)Direct7.5K shares at avg. $9.69$72K - Jul 2, 2026RGNX
REGENXBIO Inc.
Exercise(M)Direct2.2K shares at avg. $7.86$17K - Jul 2, 2026RGNX
REGENXBIO Inc.
Sale(S)Direct2.2K shares at avg. $13.64$29K - Jul 1, 2026RGNX
REGENXBIO Inc.
Exercise(M)Direct36.7K shares at avg. $7.86$289K - Jul 1, 2026RGNX
REGENXBIO Inc.
Sale(S)Direct36.7K shares at avg. $12.86$472K - Jun 29, 2026RGNX
REGENXBIO Inc.
Sale(S)Direct19.6K shares at avg. $11.04$216K - May 11, 2026RGNX
REGENXBIO Inc.
Sale(S)Direct15.3K shares at avg. $11.02$169K - Mar 10, 2026RGNX
REGENXBIO Inc.
Sale(S)Direct5.1K shares at avg. $10.35$53K - Feb 1, 2026RGNX
REGENXBIO Inc.
Tax Payment(F)Direct5.3K shares at avg. $11.16$59K - Jan 6, 2026RGNX
REGENXBIO Inc.
Award(A)Direct65.8K shares- - Jan 2, 2026RGNX
REGENXBIO Inc.
Tax Payment(F)Direct18.2K shares at avg. $14.40$263K - Feb 1, 2025RGNX
REGENXBIO Inc.
Tax Payment(F)Direct5.3K shares at avg. $8.07$42K - Jan 2, 2025RGNX
REGENXBIO Inc.
Award(A)Direct64.3K shares- - Jan 2, 2025RGNX
REGENXBIO Inc.
Tax Payment(F)Direct13.9K shares at avg. $7.73$107K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 1, 2026 | RGNX REGENXBIO Inc. | Award(A) | 34,722 | - | $0 | Direct |
| Aug 1, 2026 | RGNX REGENXBIO Inc. | Tax Payment(F) | 7,468 | $9.69 | $72,365 | Direct |
| Jul 2, 2026 | RGNX REGENXBIO Inc. | Exercise(M) | 2,161 | $7.86 | $16,985 | Direct |
| Jul 2, 2026 | RGNX REGENXBIO Inc. | Sale(S) | 2,161 | $13.64 | $29,476 | Direct |
| Jul 1, 2026 | RGNX REGENXBIO Inc. | Exercise(M) | 36,725 | $7.86 | $288,659 | Direct |
| Jul 1, 2026 | RGNX REGENXBIO Inc. | Sale(S) | 36,725 | $12.86 | $472,284 | Direct |
| Jun 29, 2026 | RGNX REGENXBIO Inc. | Sale(S) | 19,608 | $11.04 | $216,472 | Direct |
| May 11, 2026 | RGNX REGENXBIO Inc. | Sale(S) | 15,309 | $11.02 | $168,705 | Direct |
| Mar 10, 2026 | RGNX REGENXBIO Inc. | Sale(S) | 5,124 | $10.35 | $53,033 | Direct |
| Feb 1, 2026 | RGNX REGENXBIO Inc. | Tax Payment(F) | 5,267 | $11.16 | $58,780 | Direct |
| Jan 6, 2026 | RGNX REGENXBIO Inc. | Award(A) | 65,847 | - | $0 | Direct |
| Jan 2, 2026 | RGNX REGENXBIO Inc. | Tax Payment(F) | 18,247 | $14.40 | $262,757 | Direct |
| Feb 1, 2025 | RGNX REGENXBIO Inc. | Tax Payment(F) | 5,263 | $8.07 | $42,472 | Direct |
| Jan 2, 2025 | RGNX REGENXBIO Inc. | Award(A) | 64,293 | - | $0 | Direct |
| Jan 2, 2025 | RGNX REGENXBIO Inc. | Tax Payment(F) | 13,891 | $7.73 | $107,377 | Direct |
1-15 of 15 transactions
About PAKOLA STEVE
PAKOLA STEVE (SEC CIK 0001700659) files insider reports with the SEC as Chief Medical Officer of REGENXBIO Inc. (RGNX).
Signal8 holds 11 ownership filings by PAKOLA STEVE, all Form 4s, filed between Jan 6, 2025 and Nov 3, 2026. Those filings report 15 transactions, from Jan 2, 2025 to Nov 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on PAKOLA STEVE's filings is in ROCKVILLE, MD.
Recent filings by PAKOLA STEVE
- Nov 1, 2026: Grant or award of RGNX shares (Form 4, code A).
- Aug 1, 2026: Tax withholding of RGNX shares (Form 4, code F).
- Jul 2, 2026: Option exercise of RGNX shares (Form 4, code M).
- Jul 2, 2026: Open-market sale of RGNX shares (Form 4, code S).
- Jul 1, 2026: Option exercise of RGNX shares (Form 4, code M).
Other insiders filing for REGENXBIO Inc. (RGNX)
- Malzahn Craig, Chief Technology Officer
- Christmas Patrick J., Chief Strategy & Legal Officer
- Chan Mitchell, Chief Financial Officer
- Ciongoli Gregory Austin, Director
- Simpson Curran, Chief Executive Officer
- Tasse Daniel, Director